These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33554791)

  • 1. [The Antileukemia Activity of ZSTK474 on U937 Cells].
    Chen T; Zhou QX; Qiu YL; Kong DX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):17-25. PubMed ID: 33554791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells.
    Wang Y; Liu J; Qiu Y; Jin M; Chen X; Fan G; Wang R; Kong D
    Oncotarget; 2016 Apr; 7(15):19897-909. PubMed ID: 26918351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells.
    Zhou Q; Chen Y; Chen X; Zhao W; Zhong Y; Wang R; Jin M; Qiu Y; Kong D
    Int J Biol Sci; 2016; 12(6):631-8. PubMed ID: 27194941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
    Yaguchi S; Fukui Y; Koshimizu I; Yoshimi H; Matsuno T; Gouda H; Hirono S; Yamazaki K; Yamori T
    J Natl Cancer Inst; 2006 Apr; 98(8):545-56. PubMed ID: 16622124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
    Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
    Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Effects and Regulatory Mechanism of Targeting CXC Chemokine Receptor 1/2 Combined with Ara-C on the Malignant Biological Behaviors of U937 Cells of Acute Myeloid Leukemia].
    Liu YQ; Shen JZ; Yin Y; Chen YT; Yang H; Tang HW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):364-376. PubMed ID: 37096507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest.
    Dan S; Yoshimi H; Okamura M; Mukai Y; Yamori T
    Biochem Biophys Res Commun; 2009 Jan; 379(1):104-9. PubMed ID: 19094964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.
    Barollo S; Bertazza L; Baldini E; Ulisse S; Cavedon E; Boscaro M; Pezzani R; Mian C
    Invest New Drugs; 2014 Aug; 32(4):626-35. PubMed ID: 24821574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).
    Lin L; Gaut D; Hu K; Yan H; Yin D; Koeffler HP
    Int J Oncol; 2014 Feb; 44(2):557-62. PubMed ID: 24297065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
    Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
    Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo.
    Anzai K; Sekine-Suzuki E; Ueno M; Okamura M; Yoshimi H; Dan S; Yaguchi S; Enami J; Yamori T; Okayasu R
    Cancer Sci; 2011 Jun; 102(6):1176-80. PubMed ID: 21352422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivo.
    Dan S; Okamura M; Mukai Y; Yoshimi H; Inoue Y; Hanyu A; Sakaue-Sawano A; Imamura T; Miyawaki A; Yamori T
    Eur J Cancer; 2012 Apr; 48(6):936-43. PubMed ID: 22088482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blockage of mTOR signaling pathway by homoharringtonine inhibits proliferation and induces apoptosis of HT29 human colorectal tumor cells].
    Wang D; Tao W; Zhang X; You P; Mu X; Cao J; Li X; Wang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Apr; 34(4):346-353. PubMed ID: 29973326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.
    Friedrichs N; Trautmann M; Endl E; Sievers E; Kindler D; Wurst P; Czerwitzki J; Steiner S; Renner M; Penzel R; Koch A; Larsson O; Tanaka S; Kawai A; Schirmacher P; Mechtersheimer G; Wardelmann E; Buettner R; Hartmann W
    Int J Cancer; 2011 Oct; 129(7):1564-75. PubMed ID: 21128248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of Homoharringtonine with Arsenic Trioxide Induces Apoptosis of Human Acute Myeloid Leukemia Cell Line U937].
    Chen P; Jiang X; You PD; Jin Q; Yuan Q; Huang HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1649-1653. PubMed ID: 28024471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD98059 triggers G1 arrest and apoptosis in human leukemic U937 cells through downregulation of Akt signal pathway.
    Moon DO; Park C; Heo MS; Park YM; Choi YH; Kim GY
    Int Immunopharmacol; 2007 Jan; 7(1):36-45. PubMed ID: 17161815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival.
    Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T
    Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.
    Hu Y; Li L; Yin W; Shen L; You B; Gao H
    Mol Med Rep; 2014 Oct; 10(4):2051-8. PubMed ID: 25109283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.